Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 380, Issue 4, 2009, Pages 769-774

  Jiménez, Eugenio ^a   de la Blanca, Enrique Pérez ^a   Urso, Loredana ^b   González, Irene ^a   Salas, Julián ^a   Montiel, Mercedes ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b UNIVERSITY OF SALENTO   (Italy)

Author keywords

Angiotensin II; Cell signaling; Endothelial cells; Matrix metalloproteinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTISENSE OLIGONUCLEOTIDE; FOCAL ADHESION KINASE; GELATINASE A; GENISTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANGIOTENSIN II; ANTHRACENES; CELLS, CULTURED; CHROMONES; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MATRIX METALLOPROTEINASE 2; MORPHOLINES; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; UMBILICAL VEINS;

EID: 60849103468     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.142     Document Type: Article

References (34)

1. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9 (2005) 67-85
2. Wang M., Tagaki G., Asai K., Resuello R.G., Natividad F.F., Vatner D.E., Vatner S.F., and Lakatta E.G. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 41 (2003) 1308-1316
3. Luchtefeld M., Grote K., Grothusen C., Bley S., Bandlow N., Selle T., Strüber M., Haverich A., Bavendiek U., Drexler H., and Schieffer .B. Angiotensin II induces MMP-2 in a p47Phox-dependent manner. Biochem. Biophys. Res. Commun. 328 (2005) 183-188
4. 2 activates pro-matrix metalloproteinases-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-Kappa B pathway. J. Biol. Chem. 277 (2002) 30271-30282
5. Yang C., and Boyd D.D. Regulatión of matrix metalloproteinase gene expression. J. Biol. Chem. 211 (2007) 19-26
6. Contreras F., de la Parte M.A., Cabrera J., Ospino N., Israili Z.H., and Velasco M. Role of angiotensin II AT1 receptor blockers in the treatment of arterial hypertension. Am. J. Ther. 10 (2003) 401-408
7. Baer J.T., Sauer W.H., Berlin J.A., and Kimmel S.E. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients. Am. J. Cardiol. 94 (2004) 479-481
8. Coker M.L., Jolly J.R., Joffs C., Etoh T., Holder J.R., Bond B.R., and Spinale F.G. Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H543-H551
9. Walter A., Etienne-Selloum N., Sarr M., Kane M M.O., Beretz A., and Schini-Kerth V.B. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. J. Vasc. Res. 45 (2008) 386-394
10. Guo R.W., Yang L.X., Wang H., Liu B., and Wang L. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul. Pept. 147 (2008) 37-44
11. McCawley L.J., Li L., Wattenberg E.V., and Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274 (1999) 4347-4353
12. Genersch E., Hayess K., Neuenfeld Y., and Haller H. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113 (2000) 4319-4330
13. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
14. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle protein-dye binding. Anal. Biochem. 72 (1976) 248-254
15. Browatzki M., Larsen D., Pfeiffer C.A., Gehrke S.G., Schmidt J., Kranzhofer A., Katus H.A., and Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-κB and activator protein 1 in a redox-sensitive manner. J. Vasc. Res. 42 (2005) 415-423
16. Singh R., Alavi N., Singh A.K., and Leehey D.J. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 48 (1999) 2066-2073
17. Stacy L.B., Qianli Y., Horak K., and Larson D.F. Effect of angiotensin II on primary cardiac fibloblast matrix metalloproteinase activities. Perfusion 22 (2007) 51-55
18. Arenas I.A., Xu Y., Lopez-Jaramillo P., and Davidge S.T. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α. Am. J. Physiol. Cell Physiol. 286 (2004) C779-C784
19. c-Src in relation to mitogen-activated protein kinases in hepatocytes. Biochim. Biophys. Acta 158 (2002) 285-297
20. Wu X., Gan B., Yoo Y., and Guan J. FAK-mediated Src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. Dev. Cell. 9 (2005) 185-196
21. Kuo L., Chang H.C., Leu T.H., Maa M.C., and Hung W.C. Src oncogene activates MMP-2 expression via ERK/Sp1 pathway. J. Cell. Physiol. 207 (2006) 729-734
22. Cuevas B.D., Lu Y., Mao M., Zhang J., LaPushin R., Siminovitch K., and Mills G.B. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276 (2001) 27455-27461
23. Rabkin S.W., Goutsouliak V., and Kong J.Y. Angiotensin II induces activation of phosphatidylinositol 3-kinase in cardiomyocytes. J. Hypertens. 15 (1997) 891-899
24. Saward L., and Zahradka P. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ. Res. 81 (1997) 249-257
25. Risinger G.M., Hunt T.S., Updike D.L., Bullen E.C., and Howard E.W. Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors. J. Biol. Chem. 281 (2006) 25915-25925
26. Ispanovic E., and Haas T.L. JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton organization in endothelial cells. Am. J. Physiol. Cell. Physiol. 291 (2006) C579-C588
27. Steinle J.J., Meininger C.J., Forough R., Wu G., Wu M.H., and Granger H.J. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 277 (2002) 43830-44385
28. Murga C., Laguinge L., Wetzker R., Cuadrado A., and Gutkind J.S. Activation of Akt/protein kinase B by G proteincoupled receptors. A role for α and βγ subunits of heterotrimeric G proteinsacting through phosphatidylinositol-3- OH kinase γ. J. Biol. Chem. 273 (1998) 19080-19085
29. Montiel M., Gámez M.I., García-Vallejo J.J., Pérez de la Blanca E., Martín E., Quesada J., and Jiménez E. Angiotensin II effect on calcium mobilization and mitogen-activated protein kinase activation in human umbilical vein endothelial cells. Signal Transduct. 3 (2003) 201-208
30. Tang H., Zhao Z.J., Landon E.J., and Inagami T. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2. J. Biol. Chem. 275 (2000) 8389-8396
31. Chae Y.J., Kim C.H., Ha T.S., Hescheler J., Ahn H.Y., and Sachinidis A. Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell. Physiol. Biochem. 20 (2007) 859-866
32. Zaragoza C., Soria E., López E., Browning D., Balbín M., López-Otín C., and Lamas S. Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells. Mol. Pharmacol. 49 (2002) 927-935
33. Montiel M., Pérez de la Blanca E., and Jiménez E. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 327 (2005) 971-978
34. Yu J., Bian D., Mahanivong C., Cheng R.K., Zhou W., and Huang S. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J. Biol. Chem. 279 (2004) 50446-50454